[English] 日本語
Yorodumi- PDB-7o4d: QR2 inhibitor from a novel sulfanamide series to tackle age relat... -
+Open data
-Basic information
Entry | Database: PDB / ID: 7o4d | ||||||
---|---|---|---|---|---|---|---|
Title | QR2 inhibitor from a novel sulfanamide series to tackle age related oxidative stress and cognitive decline | ||||||
Components | Ribosyldihydronicotinamide dehydrogenase [quinone] | ||||||
Keywords | OXIDOREDUCTASE / Inhibitors | ||||||
Function / homology | Function and homology information ribosyldihydronicotinamide dehydrogenase (quinone) / dihydronicotinamide riboside quinone reductase activity / quinone catabolic process / resveratrol binding / oxidoreductase activity, acting on other nitrogenous compounds as donors / melatonin binding / NAD(P)H dehydrogenase (quinone) activity / Phase I - Functionalization of compounds / chloride ion binding / FAD binding ...ribosyldihydronicotinamide dehydrogenase (quinone) / dihydronicotinamide riboside quinone reductase activity / quinone catabolic process / resveratrol binding / oxidoreductase activity, acting on other nitrogenous compounds as donors / melatonin binding / NAD(P)H dehydrogenase (quinone) activity / Phase I - Functionalization of compounds / chloride ion binding / FAD binding / electron transfer activity / oxidoreductase activity / protein homodimerization activity / extracellular exosome / zinc ion binding / nucleoplasm / cytosol Similarity search - Function | ||||||
Biological species | Homo sapiens (human) | ||||||
Method | X-RAY DIFFRACTION / MOLECULAR REPLACEMENT / Resolution: 2.249 Å | ||||||
Authors | Gould, N.L. / Scherer, G.R. / Carvalh, S. / Shurrush, K. / Edry, E. / Elkobi, A. / David, O. / Dym, O. / Albeck, S. / Peleg, Y. ...Gould, N.L. / Scherer, G.R. / Carvalh, S. / Shurrush, K. / Edry, E. / Elkobi, A. / David, O. / Dym, O. / Albeck, S. / Peleg, Y. / Germain, N. / Babaev, I. / Sharir, H. / Lefker, B. / Subramanyam, C. / Barr, H. / Rosenblum, K. | ||||||
Funding support | Israel, 1items
| ||||||
Citation | Journal: J.Clin.Invest. / Year: 2023 Title: Specific quinone reductase 2 inhibitors reduce metabolic burden and reverse Alzheimer's disease phenotype in mice. Authors: Gould, N.L. / Scherer, G.R. / Carvalho, S. / Shurrush, K. / Kayyal, H. / Edry, E. / Elkobi, A. / David, O. / Foqara, M. / Thakar, D. / Pavesi, T. / Sharma, V. / Walker, M. / Maitland, M. / ...Authors: Gould, N.L. / Scherer, G.R. / Carvalho, S. / Shurrush, K. / Kayyal, H. / Edry, E. / Elkobi, A. / David, O. / Foqara, M. / Thakar, D. / Pavesi, T. / Sharma, V. / Walker, M. / Maitland, M. / Dym, O. / Albeck, S. / Peleg, Y. / Germain, N. / Babaev, I. / Sharir, H. / Lalzar, M. / Shklyar, B. / Hazut, N. / Khamaisy, M. / Levesque, M. / Lajoie, G. / Avoli, M. / Amitai, G. / Lefker, B. / Subramanyam, C. / Shilton, B. / Barr, H. / Rosenblum, K. | ||||||
History |
|
-Structure visualization
Structure viewer | Molecule: MolmilJmol/JSmol |
---|
-Downloads & links
-Download
PDBx/mmCIF format | 7o4d.cif.gz | 111.7 KB | Display | PDBx/mmCIF format |
---|---|---|---|---|
PDB format | pdb7o4d.ent.gz | 82.8 KB | Display | PDB format |
PDBx/mmJSON format | 7o4d.json.gz | Tree view | PDBx/mmJSON format | |
Others | Other downloads |
-Validation report
Summary document | 7o4d_validation.pdf.gz | 1.8 MB | Display | wwPDB validaton report |
---|---|---|---|---|
Full document | 7o4d_full_validation.pdf.gz | 1.8 MB | Display | |
Data in XML | 7o4d_validation.xml.gz | 21.6 KB | Display | |
Data in CIF | 7o4d_validation.cif.gz | 28.8 KB | Display | |
Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/o4/7o4d ftp://data.pdbj.org/pub/pdb/validation_reports/o4/7o4d | HTTPS FTP |
-Related structure data
Related structure data | 5lbuS S: Starting model for refinement |
---|---|
Similar structure data | Similarity search - Function & homologyF&H Search |
-Links
-Assembly
Deposited unit |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
Unit cell |
|
-Components
-Protein , 1 types, 2 molecules AB
#1: Protein | Mass: 27995.787 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: NQO2, NMOR2 / Production host: Escherichia coli (E. coli) References: UniProt: P16083, ribosyldihydronicotinamide dehydrogenase (quinone) |
---|
-Non-polymers , 5 types, 123 molecules
#2: Chemical | #3: Chemical | #4: Chemical | ChemComp-SO4 / | #5: Chemical | #6: Water | ChemComp-HOH / | |
---|
-Details
Has ligand of interest | Y |
---|
-Experimental details
-Experiment
Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
---|
-Sample preparation
Crystal | Density Matthews: 2.26 Å3/Da / Density % sol: 45.59 % |
---|---|
Crystal grow | Temperature: 293 K / Method: vapor diffusion, hanging drop Details: 0.7 M ammonium tartrate diabasic and 50 mM Tris pH 8.5 |
-Data collection
Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
---|---|
Diffraction source | Source: ROTATING ANODE / Type: RIGAKU / Wavelength: 1.5419 Å |
Detector | Type: RIGAKU RAXIS IV++ / Detector: IMAGE PLATE / Date: Jul 13, 2020 |
Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
Radiation wavelength | Wavelength: 1.5419 Å / Relative weight: 1 |
Reflection | Resolution: 2.249→47.07 Å / Num. obs: 24796 / % possible obs: 99.9 % / Redundancy: 10.2 % / CC1/2: 0.993 / Rmerge(I) obs: 0.2 / Rpim(I) all: 0.06999 / Rrim(I) all: 0.2292 / Net I/σ(I): 8.82 |
Reflection shell | Resolution: 2.249→2.329 Å / Redundancy: 10.2 % / Rmerge(I) obs: 0.6941 / Mean I/σ(I) obs: 3.51 / Num. unique obs: 2419 / CC1/2: 0.902 / Rpim(I) all: 0.2235 / Rrim(I) all: 0.7304 |
-Processing
Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method to determine structure: MOLECULAR REPLACEMENT Starting model: 5LBU Resolution: 2.249→47.07 Å / SU ML: 0.22 / Cross valid method: THROUGHOUT / σ(F): 1.34 / Phase error: 20.72 / Stereochemistry target values: ML
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displacement parameters | Biso max: 91.54 Å2 / Biso mean: 19.0539 Å2 / Biso min: 4.75 Å2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement step | Cycle: final / Resolution: 2.249→47.07 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS refinement shell | Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0
|